MN management has changed in 2020 onwards thanks to two trials published in 2020-2021 that showed that cyclophosphamide/steroids is superior and rituximab is not the main player yet.
The figures below summarize the main points of the GN 2021 KDIGO update
No comments:
Post a Comment